• Print

Dr. Mamoun Alhamadsheh receives NIA grant from AACP

Jan 26, 2012

Dr. Mamoun Alhamadsheh, Assistant Professor, Department of Pharmaceutics and Medicinal Chemistry, was awarded the 2011-2012 American Association of Colleges of Pharmacy (AACP) New Investigator Award (NIA) for his research titled Harnessing Transthyretin to Inhibit Extracellular Receptor-Ligand Interactions. The award was funded in the amount of $10,000 with an additional $1,000 to cover his travel expenses to present his research findings at the 2013 AACP Annual Meeting in Chicago.

"I am excited to represent Pacific and to know that I have so much support from faculty members, the Dean, and School administrators," said Dr. Alhamadsheh. "It shows that as an institution, we value education and research, and although we are a smaller university there is a collaborative environment that is flexible and supportive of research," he added.

The NIA provides start-up funding for new pharmacy faculty's research programs and receives more than 200 applications a year. Dr. Alhamadsheh's proposal received one of 18 grants.

Dr. Alhamadsheh's research will focus on developing a new strategy for inhibiting protein-protein interactions, which can be used to target multiple diseases such as Alzheimer's and cancer. If successful, his research will provide a more stable, less toxic, and inexpensive alternative for targeting antibodies.

In August 2011, Dr. Alhamadsheh has his article Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity published and featured on the cover of Science Translational Medicine magazine. It was also mentioned in the Chemical & Engineering News published by the American Chemical Society and The Alzheimer's Research Forum. This article will serve as the foundation for his research.

about the author

Dua Moua   Dua Moua '09 is the Marketing Communications Assistant at the Thomas J. Long School of Pharmacy and Health Sciences at Pacific.